BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23295558)

  • 1. Clostridium difficile infection and limitations of markers for severity in patients with hematologic malignancy.
    Wang MS; Evans CT; Rodriguez T; Gerding DN; Johnson S
    Infect Control Hosp Epidemiol; 2013 Feb; 34(2):127-32. PubMed ID: 23295558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case fatality associated with a hypervirulent strain in patients with culture-positive Clostridium difficile infection: a retrospective population-based study.
    Huttunen R; Vuento R; Syrjänen J; Tissari P; Aittoniemi J
    Int J Infect Dis; 2012 Jul; 16(7):e532-5. PubMed ID: 22572612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
    Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
    Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
    Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
    Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008.
    Feuerstadt P; Das R; Brandt LJ
    Am J Gastroenterol; 2014 Aug; 109(8):1265-76. PubMed ID: 25001255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predictive of severe Clostridium difficile infection depend on the definition used.
    Khanafer N; Barbut F; Eckert C; Perraud M; Demont C; Luxemburger C; Vanhems P
    Anaerobe; 2016 Feb; 37():43-8. PubMed ID: 26335160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of serious complications due to Clostridium difficile infection.
    Gujja D; Friedenberg FK
    Aliment Pharmacol Ther; 2009 Mar; 29(6):635-42. PubMed ID: 19077106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
    Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical severity score indices for Clostridium difficile infection.
    Fujitani S; George WL; Murthy AR
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):220-8. PubMed ID: 21460506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
    J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emergence of community-onset Clostridium difficile infection in a tertiary hospital in Singapore: a cause for concern.
    Tan XQ; Verrall AJ; Jureen R; Riley TV; Collins DA; Lin RT; Balm MN; Chan D; Tambyah PA
    Int J Antimicrob Agents; 2014 Jan; 43(1):47-51. PubMed ID: 24290727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.
    Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE
    Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
    Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
    JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan.
    Hung YP; Tsai CS; Tsai BY; Tsai PJ; Lee YT; Lee JC; Liu HC; Hsueh PR; Lee CC; Ko WC
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1101-1110. PubMed ID: 33678554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile outbreak strain BI is highly endemic in Chicago area hospitals.
    Black SR; Weaver KN; Jones RC; Ritger KA; Petrella LA; Sambol SP; Vernon M; Burton S; Garcia-Houchins S; Weber SG; Lavin MA; Gerding D; Johnson S; Gerber SI
    Infect Control Hosp Epidemiol; 2011 Sep; 32(9):897-902. PubMed ID: 21828970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum markers for severe Clostridium difficile infection in immunosuppressed hospitalized patients.
    Pant C; Sferra TJ; Ondrade C; Bass PF; Deshpande A; Burton CV
    J La State Med Soc; 2011; 163(2):91-4. PubMed ID: 21667802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.